Antibodies targeting talaromyces marneffei mp1p protein and methods of use thereof
US-2024199726-A1 · Jun 20, 2024 · US
US8962345B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8962345-B2 |
| Application number | US-201113112822-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 20, 2011 |
| Priority date | May 21, 2010 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of characterizing glycans attached to glycoproteins is disclosed herein. The method comprises a first step of immobilizing the glycoproteins on colloidal particles forming glycoprotein/colloidal particles. The glycans on the glycoproteins may then be characterized, for example the composition and/or structure of glycans may be characterized or the glycans attached to proteins may be identified. Characterization may be accomplished by either binding the glycoprotein/colloidal particles with one or more binding agents and assessing the aggregation of the glycoprotein/colloidal particles or by cleaving glycans from the glycoprotein/colloidal particles with a cleaving agent and analyzing the glycans.
Opening claim text (preview).
The invention claimed is: 1. A method of characterizing glycans attached to glycoproteins comprising the steps of: a) spontaneously immobilizing said glycans attached to glycoproteins on colloidal particles forming glycoprotein/colloidal particles; b) optically assessing the glycoprotein/colloidal particles or measuring their size; c) aggregating said glycoprotein/colloidal particles with a binding agent forming an aggregate; d) optically assessing the aggregate or measuring…
Physics · mapped topic
Physics · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.